investorscraft@gmail.com

Intrinsic Value of Sabra Health Care REIT, Inc. (SBRA)

Previous Close$18.46
Intrinsic Value
Upside potential
Previous Close
$18.46

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Sabra Health Care REIT, Inc. is a specialized real estate investment trust (REIT) focused on the healthcare sector, primarily owning and leasing skilled nursing, senior housing, and behavioral health facilities. The company generates revenue through long-term triple-net leases, where tenants cover property expenses, providing stable cash flows. Sabra operates in a niche segment of the healthcare real estate market, benefiting from demographic tailwinds such as an aging population and increasing demand for post-acute care services. Its portfolio is diversified across operators and geographies, mitigating concentration risk while maintaining a focus on high-quality assets. The REIT’s market position is strengthened by its disciplined capital allocation and partnerships with leading healthcare providers, ensuring occupancy stability and rent coverage. Sabra’s strategy emphasizes balance sheet strength and selective acquisitions to enhance portfolio quality and yield.

Revenue Profitability And Efficiency

Sabra reported revenue of $703.2 million for FY 2024, with net income of $126.7 million and diluted EPS of $0.54. Operating cash flow stood at $310.5 million, reflecting strong cash generation from its lease-based model. The absence of capital expenditures highlights the REIT’s asset-light structure, where tenants bear maintenance costs. This efficiency supports consistent dividend distributions and reinvestment capacity.

Earnings Power And Capital Efficiency

The company’s earnings power is underpinned by its triple-net lease structure, which minimizes operational volatility. With $310.5 million in operating cash flow, Sabra demonstrates robust capital efficiency, translating into a cash flow yield that supports its dividend policy. The REIT’s focus on high-quality tenants and long-term leases enhances earnings stability, though sector-specific risks such as regulatory changes remain a consideration.

Balance Sheet And Financial Health

Sabra maintains a balanced financial position, with $60.5 million in cash and equivalents against $2.44 billion in total debt. The debt level is manageable given the REIT’s stable cash flows, though leverage metrics warrant monitoring. The absence of near-term maturities and access to diversified funding sources provide liquidity flexibility, supporting its investment-grade profile.

Growth Trends And Dividend Policy

Growth is driven by strategic acquisitions and organic rent escalations, though the pace is tempered by sector headwinds. Sabra’s dividend of $1.20 per share reflects a payout ratio aligned with cash flow, offering a yield attractive to income-focused investors. The REIT’s disciplined capital recycling and focus on high-margin assets position it for sustainable growth.

Valuation And Market Expectations

The market values Sabra based on its stable cash flows and dividend yield, with a focus on occupancy trends and tenant health. Valuation multiples reflect sector risks, including reimbursement pressures and operator stability. Investor expectations hinge on Sabra’s ability to maintain rent coverage and navigate healthcare industry dynamics.

Strategic Advantages And Outlook

Sabra’s key advantages include its sector specialization, diversified tenant base, and conservative leverage. The outlook is cautiously optimistic, with growth opportunities in behavioral health and senior housing offsetting skilled nursing challenges. The REIT’s focus on operational resilience and strategic capital deployment positions it to capitalize on long-term demographic trends.

Sources

10-K, company filings

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount